Ostenfeld, T., Ivanavicius, S., Stancik, R., & Conaghan, P. G. (2024). POS1153 PRELIMINARY EVALUATION OF THE SAFETY AND ANALGESIC EFFICACY OF THE TRPV1 AGONIST RTX-GRT7039 IN KNEE OSTEOARTHRITIS: A RANDOMISED, DOUBLE-BLIND, EXPLORATORY PHASE II STUDY. Annals of the rheumatic diseases, 83(Suppl 1), 667-668. https://doi.org/10.1136/annrheumdis-2024-eular.4306
Chicago Style (17th ed.) CitationOstenfeld, T., S. Ivanavicius, R. Stancik, and P. G. Conaghan. "POS1153 PRELIMINARY EVALUATION OF THE SAFETY AND ANALGESIC EFFICACY OF THE TRPV1 AGONIST RTX-GRT7039 IN KNEE OSTEOARTHRITIS: A RANDOMISED, DOUBLE-BLIND, EXPLORATORY PHASE II STUDY." Annals of the Rheumatic Diseases 83, no. Suppl 1 (2024): 667-668. https://doi.org/10.1136/annrheumdis-2024-eular.4306.
MLA (9th ed.) CitationOstenfeld, T., et al. "POS1153 PRELIMINARY EVALUATION OF THE SAFETY AND ANALGESIC EFFICACY OF THE TRPV1 AGONIST RTX-GRT7039 IN KNEE OSTEOARTHRITIS: A RANDOMISED, DOUBLE-BLIND, EXPLORATORY PHASE II STUDY." Annals of the Rheumatic Diseases, vol. 83, no. Suppl 1, 2024, pp. 667-668, https://doi.org/10.1136/annrheumdis-2024-eular.4306.